• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Cantor Fitzgerald sets $20 price target for Core Scientific stock: Should you buy?

by July 18, 2024
written by July 18, 2024

Core Scientific Inc (NASDAQ: CORZ) has recently been garnering a lot of attention from financial analysts. On Wednesday, Cantor Fitzgerald initiated coverage of the company, assigning an “overweight” rating with a compelling $20.00 price target.

This suggests a substantial upside of nearly 71% from the current stock price, signaling strong confidence in the company’s future prospects.

Concurrently, today B. Riley Securities upgraded their rating on Core Scientific from Neutral to Buy, driven by the company’s strategic expansion into high-performance computing (HPC) hosting.

The upgrade by B. Riley Securities stems from Core Scientific’s recent deals, particularly with CoreWeave. Analyst Lucas Pipes highlighted the company’s potential to become a leader in the HPC space.

This optimism is supported by a series of long-term contracts with CoreWeave, expected to generate over $3.5 billion in revenue across the next 12 years.

These contracts not only signify a robust revenue stream but also mark a strategic pivot towards leveraging Core Scientific’s extensive infrastructure for AI data centers—a growing industry demand.

Bernstein analyst Gautam Chhugani also provided a positive outlook on July 10th, starting coverage of Core Scientific with an “Outperform” rating.

Chhugani emphasized the company’s ideal setup for AI data center collaboration due to its power infrastructure and operational capabilities.

He anticipates a significant portion of the company’s power capacity, about 20%, transitioning to support AI by 2027, reinforcing the strategic shift towards diversified high-value compute services.

Financial performance and business challenges

Core Scientific’s financial results underscores these strategic advancements. The company reported a GAAP EPS of $0.78 for Q1 2024, with revenue reaching $179.29 million, marking a 48.6% increase year-over-year.

This robust financial performance is rooted in both its traditional bitcoin mining operations and its burgeoning HPC services, with a net income of $210.7 million highlighting operational efficiency and profitability.

However, Core Scientific’s journey has seen its challenges. Despite the strategic expansions, the company faced a momentary dip when it updated its June production figures, showing a decrease in bitcoin mined compared to the previous month.

Yet, this was quickly overshadowed by the overall positive momentum driven by analyst upgrades and operational successes.

CoreWeave’s bid

In a notable event earlier in June, Core Scientific rejected an unsolicited proposal from CoreWeave to acquire the company at $5.75 per share, which it considered undervalued.

This proposal came shortly after Core Scientific disclosed the lucrative 12-year contracts with CoreWeave, indicating significant external interest and perceived value in Core Scientific’s operational and strategic direction.

This series of developments—from analyst upgrades, strategic pivots towards HPC hosting, to handling unsolicited acquisition offers—positions Core Scientific positively in the eyes of investors.

With all these facets considered, Core Scientific represents a multifaceted investment opportunity, poised for potential growth in both its established and emerging business areas.

Now, as we turn toward the technical analysis, we will assess how these fundamental strengths and strategic initiatives are reflected in Core Scientific’s stock price movements and what the charts might indicate about its future trajectory.

Super strong short-term momentum

In January this year, Core Scientific emerged from bankruptcy, completed its reorganization process and relisted its shares on the Nasdaq.

The stock entered a bullish phase in May this year when it was trading below $3.

CORZ by TradingView

Following the bid from CoreWeave, the stock skyrocketed in June and that strong rally has resulted in it appreciating more than 400% from its April lows.

The stock continues to enjoy strong bullish momentum hence short-term traders must refrain from shorting it currently.

Investors who are bullish on the company’s prospects and are looking to enter long positions must try to accumulate it at levels below $11 with a stop loss at $8.9, which has been acting as a strong support since late June.

If the bullish momentum continues, the stock might reach the price target assigned by Cantor Fitzgerald in the coming months.

The post Cantor Fitzgerald sets $20 price target for Core Scientific stock: Should you buy? appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Ripple and Tron: Ripple is moving to the bearish side again
next post
Render (RNDR) hits crucial user milestone ahead of much-anticipated token swap

related articles

Asian markets close: Nikkei, Kospi down; Sensex closes...

May 19, 2025

Qualcomm unveils AI chips for data centres with...

May 19, 2025

Best crypto to buy now: Bitcoin Pepe leads...

May 19, 2025

JPMorgan cuts Netflix rating, citing balanced risk-reward post-rally;...

May 19, 2025

Bitcoin ETF open interest dips 5% to $29.47B...

May 19, 2025

US stocks slip in the red on Monday:...

May 19, 2025

Should Klarna IPO remain on watch list after...

May 19, 2025

Why this brokerage downgraded UnitedHealth’s rating to ‘hold’

May 19, 2025

Nvidia opens NVLink Fusion ecosystem, expands Taiwan footprint...

May 19, 2025

Cathie Wood says Trump’s tariffs could unlock tech...

May 19, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Hegseth signs ‘No More Walking on Eggshells’ policy, demands review of equal opportunity complaint process

    April 25, 2025
  • Bitcoin Hits $88,000 All-Time High, Ethereum Surges 5.91%

    November 15, 2024
  • Long ENLV: Enlivex Announces Positive Allocetra™ Trial Results, Triggering Bullish Market Reaction

    December 4, 2024
  • EURGBP and EURCHF: EURGBP has a chance for a recovery

    September 2, 2024
  • Biden approves $500M Ukraine security package 11 days before Trump takes office

    January 9, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (4,735)
  • Investing (624)
  • Stock (775)

Latest Posts

  • Israel reimposes blockade of northern Gaza, including capital Gaza City

    March 20, 2025
  • Trump budget bill standoff fuels tension in House GOP as leaders press forward

    February 11, 2025
  • McCarthy’s ‘final struggles’ threaten to haunt Johnson’s government shutdown fight

    September 4, 2024

Recent Posts

  • Top 5 moments from Rubio’s Senate confirmation hearing: ‘I get bilingual protesters’

    January 16, 2025
  • Lindsey Graham puts Amazon ‘on notice’ over Alexa’s potential election interference

    September 4, 2024
  • Bond markets tumble as year-end trading amplifies rate cut concerns

    December 27, 2024

Editor’s Pick

  • Rubio doubts ‘anything productive’ will happen in Ukraine peace talks without Trump, Putin

    May 15, 2025
  • Harris claims Trump win would be ‘catastrophic’ for Social Security, but first term tells different tale

    October 22, 2024
  • Trump announces new ‘serious power’ fighter jets for Michigan Guard base to replace aging A-10s

    April 29, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock